Concord Biotech Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Sudhir Vaid
Chief executive officer
₹48.0m
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 24.5yrs |
CEO ownership | 38.5% |
Management average tenure | 2.7yrs |
Board average tenure | 7.8yrs |
Recent management updates
Recent updates
Concord Biotech Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 14Do Concord Biotech's (NSE:CONCORDBIO) Earnings Warrant Your Attention?
Sep 15Concord Biotech Limited (NSE:CONCORDBIO) Not Lagging Market On Growth Or Pricing
Jul 23Is Concord Biotech (NSE:CONCORDBIO) Using Too Much Debt?
Feb 14CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹3b |
Jun 30 2024 | n/a | n/a | ₹3b |
Mar 31 2024 | ₹48m | ₹48m | ₹3b |
Dec 31 2023 | n/a | n/a | ₹3b |
Sep 30 2023 | n/a | n/a | ₹3b |
Jun 30 2023 | n/a | n/a | ₹2b |
Mar 31 2023 | ₹50m | ₹50m | ₹2b |
Mar 31 2022 | ₹243m | ₹40m | ₹2b |
Mar 31 2021 | ₹40m | n/a | ₹2b |
Mar 31 2020 | ₹40m | n/a | ₹2b |
Compensation vs Market: Sudhir's total compensation ($USD568.42K) is about average for companies of similar size in the Indian market ($USD590.37K).
Compensation vs Earnings: Sudhir's compensation has been consistent with company performance over the past year.
CEO
Sudhir Vaid (72 yo)
24.5yrs
Tenure
₹48,000,000
Compensation
Mr. Sudhir Jairam Vaid served as the Chief Executive Officer at Concord Biotech Limited since April 1, 2019. Mr. Vaid is responsible for ensuring efficient and effective functioning of the organization as...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | no data | ₹48.00m | 38.46% ₹ 81.2b | |
Joint MD | 3.4yrs | ₹27.60m | 1.08% ₹ 2.3b | |
Chief Financial Officer | 2.7yrs | ₹5.75m | no data | |
Company Secretary | no data | ₹4.23m | 0.016% ₹ 34.3m | |
VP of Sales & Marketing and Head of Limbasi Plant-3 | no data | no data | 0.0077% ₹ 16.3m | |
VP of Formulation Division & Head of Valthera Unit-2 | 2.7yrs | no data | no data | |
General Manager | no data | no data | no data |
2.7yrs
Average Tenure
Experienced Management: CONCORDBIO's management team is considered experienced (2.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | 24.5yrs | ₹48.00m | 38.46% ₹ 81.2b | |
Joint MD | 13.2yrs | ₹27.60m | 1.08% ₹ 2.3b | |
Independent Non Executive Director | 2.4yrs | ₹400.00k | no data | |
Non-Executive Director | 16.4yrs | ₹400.00k | 0.12% ₹ 263.5m | |
Independent Non Executive Director | 7.8yrs | ₹300.00k | no data | |
Independent Non Executive Director | 2.5yrs | ₹400.00k | 0.0010% ₹ 2.2m | |
Non-Executive Director | 20.9yrs | ₹400.00k | 0.20% ₹ 424.0m | |
Independent Non Executive Woman Director | 7.8yrs | ₹400.00k | no data | |
Independent Non Executive Director | 2.4yrs | ₹350.00k | no data |
7.8yrs
Average Tenure
64yo
Average Age
Experienced Board: CONCORDBIO's board of directors are considered experienced (7.8 years average tenure).